As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...

The latest round of tests come as the U.S. dairy industry continues to battle the outbreak of HPAI H5N1 in cows ... “It is actually expected that RNA will remain in the milk after pasteurization.

a messenger RNA-based vaccine candidate, to address unmet medical needs for the prevention of disease caused by pandemic influenza A virus H5N1. The FDA's fast-track program is designed to ...

RNA polymerase is an enzyme that is responsible for copying a DNA sequence into an RNA sequence, duyring the process of transcription. As complex molecule composed of protein subunits, RNA ...

Strong genetic evidence makes it highly likely that a dairy farm worker in Texas contracted avian influenza A (H5N1) from cattle ... time reverse transcription polymerase chain reaction (RT ...

As highly pathogenic H5N1 avian influenza continues to spread ... Scientists previously had to use slower detection methods ...

One such strain, highly pathogenic avian influenza (HPAI) H5N1 ... polymerase chain reaction (qPCR) on the QuantStudio 3 platform, the team found no evidence of influenza A viral RNA.

Each nucleocapsid protein-encapsidated RNA segment, together with its heterotrimeric polymerase, constitutes a viral ribonucleoprotein complex. Although consisting of only eight genomic segments ...

SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (ARCT), a commercial messenger RNA medicine company ... disease caused by influenza A H5N1 subtype contained in the vaccine.